PubRank

Aye Aye Thike

Author PubWeight™ 29.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res 2013 1.67
2 Diagnostic issues in second opinion consultations in prostate pathology. Pathology 2010 1.42
3 Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol 2011 1.38
4 Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol 2010 1.29
5 Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast 2010 1.04
6 p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res 2012 0.99
7 DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest 2014 0.97
8 TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res 2012 0.95
9 Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol 2010 0.94
10 Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer. Histopathology 2012 0.94
11 Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms. Histopathology 2010 0.93
12 Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Int J Oncol 2010 0.87
13 Mucin extravasation in breast core biopsies--clinical significance and outcome correlation. Histopathology 2009 0.87
14 Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer. Breast Cancer Res Treat 2015 0.86
15 HER2/neu revisited: quality and interpretive issues. J Clin Pathol 2010 0.84
16 Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer. Histopathology 2014 0.84
17 Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer. Arch Pathol Lab Med 2016 0.81
18 Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram. J Clin Pathol 2013 0.81
19 Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome. Histopathology 2013 0.80
20 Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups. Breast Cancer Res Treat 2014 0.80
21 Histiocytoid breast carcinoma: an enigmatic lobular entity. J Clin Pathol 2011 0.80
22 Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression. Breast Cancer Res Treat 2010 0.79
23 Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions. J Clin Pathol 2012 0.79
24 Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat 2015 0.79
25 Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: clinical relevance and prognostic significance. J Clin Pathol 2013 0.78
26 Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat 2015 0.77
27 Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast. Am J Surg Pathol 2016 0.76
28 Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat 2015 0.76
29 Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast. Breast Cancer Res Treat 2015 0.76
30 Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome. Histopathology 2014 0.76
31 Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival. J Clin Pathol 2010 0.76
32 Intranuclear inclusions in epithelial cells of benign proliferative breast lesions. J Clin Pathol 2011 0.76
33 Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification. Breast Cancer Res Treat 2011 0.76
34 Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. Singapore Med J 2014 0.75